Search for other papers by Kira Bang Bové in
Google Scholar
PubMed
Institute of Public Health, University of Copenhagen, Odense, Denmark
Search for other papers by Torquil Watt in
Google Scholar
PubMed
Search for other papers by Asmus Vogel in
Google Scholar
PubMed
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
National Research Centre for the Working Environment, Copenhagen, Odense, Denmark
Search for other papers by Jakob Bue Bjoerner in
Google Scholar
PubMed
Department of Palliative Medicine, Bispebjerg Hospital, Odense, Denmark
Search for other papers by Mogens Groenvold in
Google Scholar
PubMed
Search for other papers by Steen Joop Bonnema in
Google Scholar
PubMed
Search for other papers by Åse Krogh Rasmussen in
Google Scholar
PubMed
Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed
Introduction Anxiety and depression are common mental disorders affecting the general population [ 1 ]. They are often found in patients with chronic somatic diseases, among these thyroid dysfunction [ 2 ]. Hypothyroidism has been linked to
Clinical Institute, Aalborg University, Aalborg, Denmark
Search for other papers by Jesper Karmisholt in
Google Scholar
PubMed
Clinical Institute, Aalborg University, Aalborg, Denmark
Search for other papers by Stig Andersen in
Google Scholar
PubMed
distributed for completion at the participants’ home and subsequently returned by postal delivery. The questionnaires used were: Danish version 1 of the SF-36 [ 13 ], a Danish version of the Hospital Anxiety and Depression Scale (HADS) [ 14 ], and the
Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Birgitta Johansson in
Google Scholar
PubMed
Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Wallenberg’s Centre of Molecular and Translational Medicine, Region Västra Götaland, Sweden
Search for other papers by Mats Holmberg in
Google Scholar
PubMed
Department of Pedagogical, Curricular and Professional Studies, Faculty of Education, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Simon Skau in
Google Scholar
PubMed
Search for other papers by Helge Malmgren in
Google Scholar
PubMed
Wallenberg’s Centre of Molecular and Translational Medicine, Region Västra Götaland, Sweden
Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Helena Filipsson Nyström in
Google Scholar
PubMed
majority will report no residual problems. However, some will still struggle with a reduced quality of life (QoL), fatigue, depression, anxiety, and cognitive complaints and will experience problems with returning to work ( 1 , 2 , 3 , 4 , 5 , 6 , 7
Institute of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden
Wallenberg’s Centre of Molecular and Translational Medicine, Region Västra Götaland, Sweden
Search for other papers by Mats Holmberg in
Google Scholar
PubMed
Search for other papers by Helge Malmgren in
Google Scholar
PubMed
Search for other papers by Peter F Berglund in
Google Scholar
PubMed
Search for other papers by Birgitta Johansson in
Google Scholar
PubMed
Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden
Department of Endocrinology, Sahlgrenska University Hospital, Göteborg, Sweden
Gothenburg Centre for Person Centred-Care (GPCC), Göteborg, Sweden
Search for other papers by Helena Filipsson Nyström in
Google Scholar
PubMed
-analysis) the most prevalent mental symptoms included anxiety, fatigue, emotional lability, and reduced emotional well-being ( 1 ). These symptoms are often ameliorated by the restoration of thyroid hormone levels to normal by treatment, but a considerable
Search for other papers by Jan Calissendorff in
Google Scholar
PubMed
Centre for Clinical Research in Sörmland, Uppsala University, Uppsala, Sweden
Search for other papers by Emil Mikulski in
Google Scholar
PubMed
Search for other papers by Erik H. Larsen in
Google Scholar
PubMed
Centre for Clinical Research in Sörmland, Uppsala University, Uppsala, Sweden
Search for other papers by Marika Möller in
Google Scholar
PubMed
hormones and low thyroid-stimulating hormone (TSH). Patients typically develop physical and mental symptoms such as tachycardia, weight loss, sweating, muscle weakness, tremor and anxiety [ 2 ]. Medication blocking the thyroid hormone synthesis is one
Institute of Public Health, University of Copenhagen
Search for other papers by Torquil Watt in
Google Scholar
PubMed
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
National Research Centre for the Working Environment, Copenhagen
Search for other papers by Jakob Bue Bjorner in
Google Scholar
PubMed
Department of Palliative Medicine, Bispebjerg Hospital
Search for other papers by Mogens Groenvold in
Google Scholar
PubMed
Search for other papers by Steen Joop Bonnema in
Google Scholar
PubMed
Search for other papers by Åse Krogh Rasmussen in
Google Scholar
PubMed
Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed
related to QoL scores. TPOAb levels were statistically significantly associated with several QoL dimensions: Goitre Symptoms (p = 0.024), Depressivity (p = 0.004), Anxiety (p = 0.004), Emotional Susceptibility (p = 0.005) and Impaired Social Life (p = 0
Search for other papers by M Grussendorf in
Google Scholar
PubMed
Search for other papers by I Ruschenburg in
Google Scholar
PubMed
Search for other papers by G Brabant in
Google Scholar
PubMed
well be underestimated because some thyroid cancers will be initially missed and will only be detected during long-term follow-up due to their low growth rates. The diagnosis of a new thyroid nodule will cause anxiety in the patient ( 9 , 10 ) and
Search for other papers by Frederick Keen in
Google Scholar
PubMed
Search for other papers by Anuja Chalishazar in
Google Scholar
PubMed
Search for other papers by Kelly Mitchem in
Google Scholar
PubMed
Search for other papers by Alan Dodd in
Google Scholar
PubMed
Search for other papers by Atul Kalhan in
Google Scholar
PubMed
medications and isolated CeH could lead to alleviating anxiety in patients (related to the possibility of organic/structural pituitary lesions) and the avoidance of further radiological investigations. A larger observational study is needed to provide
Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden
The National Task Force in Hyperthyroidism, Swedish National System for Knowledge-Driven Management, Umeå, Sweden
Search for other papers by Agneta Lindo in
Google Scholar
PubMed
Department of Endocrinology and Diabetes, Örebro University Hospital, Örebro, Sweden
Search for other papers by Anne Breikert in
Google Scholar
PubMed
Thyroid Federation International, Kungsbacka, Sweden
Search for other papers by Peter Lakwijk in
Google Scholar
PubMed
Swedish Thyroid Association, Stockholm, Sweden
Search for other papers by Christin Lundberg in
Google Scholar
PubMed
Swedish Thyroid Association, Stockholm, Sweden
Search for other papers by Katarina Lunner in
Google Scholar
PubMed
Search for other papers by Birgitta Johansson in
Google Scholar
PubMed
Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden
The National Task Force in Hyperthyroidism, Swedish National System for Knowledge-Driven Management, Umeå, Sweden
Sweden and Wallenberg Center for Molecular and Translational Medicine, Västra Götaland Region, Göteborg, Sweden
Search for other papers by Helena Filipsson Nyström in
Google Scholar
PubMed
) were whether the treatment affected activities of daily living, concerns about the use of RAI, possibility of depression or anxiety, and doctor's recommendations. Satisfaction was high with all three treatment types. In another study ( 15 ), only 10% of
Search for other papers by Wilmar M. Wiersinga in
Google Scholar
PubMed
Search for other papers by Leonidas Duntas in
Google Scholar
PubMed
Search for other papers by Valentin Fadeyev in
Google Scholar
PubMed
Search for other papers by Birte Nygaard in
Google Scholar
PubMed
Search for other papers by Mark P.J. Vanderpump in
Google Scholar
PubMed
and GHQ [ 12 ]. Similar correlations were seen with TSQ, but not with Hospital Anxiety and Depression Scale (HADS) scores. Another community-based study from The Netherlands investigated 141 patients who had been on L-T4 replacement for primary